无锡航亚科技股份有限公司

DSP-groep

[See below for English] DSP-groep is een onafhankelijk, landelijk opererend bureau voor beleidsonderzoek, beleidsadvies en (interim)management, met 36 medewerkers, gevestigd in Amsterdam. Wij werken in opdracht van de overheid (ministeries, provincies, gemeenten, politie), maar ook van maatschappelijke organisaties en bedrijven. DSP-groep is actief op de thema's Zorg, Sociaal Domein, Veiligheid, Wonen & Zorg, Jeugd, Cultuur en media en Sport en bewegen. Meer weten? Bel: 020-6257537. Mail: [email protected] Surf: www.dsp-groep.nl Kom langs: Van Diemenstraat 410, Amsterdam (ingang nr. 408) [English] DSP-groep is a leading institute for policy research, consultancy and social innovation, established in 1984 and based in Europe (Amsterdam-NL). Our areas of expertise include Crime prevention, Safety and (social) security, Youth, Welfare and Health care, Leisure/Sports and Culture. We carry out assignments for national and international clients and have a broad network of professionals and experts all over Europe. Like to know more? Ph: +31-20 6257537 I [email protected]. Our office is situated near Amsterdam Central Station and Amsterdam Airport Schiphol (20 minutes).

Gentronix Limited

Gentronix is a specialist CRO focused on delivering predictive toxicology products & services to global chemical sectors. Working with companies from early screening through to regulatory safety assessment, we deliver innovative solutions for both genetic toxicology and skin sensitisation. For 20 years, Gentronix Ltd has provided predictive toxicology solutions to global chemical industries; enabling our clients to optimise their development programmes via early identification of genotoxic hazard and assessment of chemical safety. Gentronix offers a comprehensive portfolio of screening and regulatory genotoxicity products & services, along with assessment of skin sensitisation potential.

Cell Therapies Pty Ltd

Cell Therapies Pty Ltd is a contract development and manufacturing organization (CDMO) that manufactures and deploys advanced cell-based therapies to the global market. Established in 2003, Cell Therapies Pty Ltd is one of the most experienced cGMP compliant manufacturers for cell therapies, gene therapies, cellular immunotherapies and regenerative medicine products globally. Working closely with its clinical and research collaborators at the Peter MacCallum Cancer Centre (http://petermac.org), Cell Therapies Pty Ltd provides its clients with needle-to-needle solutions for apheresis collection, GMP manufacturing, cryopreservation, state of the art imaging (real-time in vivo cell tracking) and clinical trial implementation. Cell Therapies Pty Ltd has a 10-cleanroom GMP facility located in Melbourne, Australia at the heart of the biomedical precinct, with access to hospitals, research institutes and universities to support development, translation and patient access. This facility holds both commercial supply and clinical trial manufacturing licenses from the Australian Therapeutic Goods Administration (TGA), ensuring the products from our facility meet global regulatory standards. We have a proven track record of delivering cell-based therapeutic products to patients from early phase clinical trials through to commercial supply according to the requirements of local and international regulators. We have also established multi-continental manufacturing networks to support trials concurrently registered in Europe, Asia and North America and have an enviable track record for efficient and successful tech transfer inbound and outbound to our collaborators. Please contact us through our website to discuss potential collaborations.

CODA / CERVA

CODA-CERVA, a federal science establishment, is the national reference laboratory for contagious animal diseases, mycotoxins and trace elements in human and animal food. CODA-CERVA contributes in the form of scientific research, expert opinions and service provision to a proactive policy in the area of safety vis-à-vis food production, animal health and public health at the level of federal and international health. It supports the preparation of policy for SPF Public Health, Food Chain Safety and Environment and the activities of the Food Agency (AFSCA). Through its tradition and expertise built up over many years, it occupies a central position between public health and agriculture. In this way, it makes a conscious effort to contribute an adapted response to new challenges for the authorities and the consumer. The essential activities of CODA-CERVA consist in scientific research to support the authorities, expertise and efficient service provision in the following areas: • Transmittable epidemic, endemic and emerging diseases in animals; • Zoonoses and emerging infectious diseases which pose a threat to public health; • Contaminants and the quality of the environment within the framework of food production safety; • Epidemiology: surveillance, risk analyses and molecular epidemiology. More than 85 researchers and 105 laboratory workers work at CODA-CERVA, along with around fifty people in support services.